Related Experiment Video
Updated: Jul 14, 2026

A Preclinical Model of Exertional Heat Stroke in Mice
Published on: July 1, 2021
Stress-induced hyperthermia: effects of acute and repeated dosing of MPEP
Rebecca E Nordquist1, Sean Durkin, Georg Jaeschke
1F. Hoffmann-La Roche Ltd., PRBD-N, Psychiatry Disease Area, CH-4070 Basel, Switzerland.
Abstract:
The mGlu5 receptor antagonist 2-methyl-6-(phenylethylnyl)-pyridine (MPEP) is highly anxiolytic in rodent models of anxiety. Recent studies showed that MPEP remains effective in some models of anxiety after repeated treatment, but tolerance may develop in other models. To further evaluate anxiolytic properties of repeated MPEP, a single administration of 3, 10, or 30 mg/kg p.o. and repeated administration of 30 mg/kg p.o. was tested in the stress-induced hyperthermia model in mice. MPEP dose-dependently inhibited stress-induced hyperthermia when given acutely. MPEP remained equally active in reducing stress-induced hyperthermia after five daily treatments with 30 mg/kg, further validating MPEP as a potential anxiolytic for chronic use.
Insights
The mGluR5 antagonist MPEP shows anxiolytic effects in mice. Repeated MPEP treatment did not diminish its effectiveness in reducing stress-induced hyperthermia, suggesting potential for chronic anxiety treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- The metabotropic glutamate receptor 5 (mGluR5) antagonist MPEP exhibits anxiolytic properties in animal models.
- Previous research indicates that MPEP's efficacy can vary with repeated administration, with tolerance developing in some anxiety models.
Purpose of the Study:
- To investigate the anxiolytic efficacy of repeated MPEP administration in a mouse model.
- To determine if tolerance develops to the effects of MPEP after daily treatment.
Main Methods:
- Acute administration of MPEP (3, 10, or 30 mg/kg, p.o.) and repeated daily administration (30 mg/kg, p.o. for five days) were tested.
- The stress-induced hyperthermia model in mice was used to assess anxiolytic effects.
Main Results:
- MPEP demonstrated a dose-dependent inhibition of stress-induced hyperthermia following acute administration.
- Following five daily treatments, MPEP at 30 mg/kg retained its efficacy in reducing stress-induced hyperthermia.
Conclusions:
- MPEP maintains its anxiolytic activity even after repeated daily administration.
- These findings support the potential of MPEP as an anxiolytic agent for chronic use in managing anxiety disorders.
Related Concept Videos
Increased Body Temperature
Homeostatic Imbalances in Body Temperature
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

